Mum sheds 2st in two months after years of weight struggles

Sarah Hill, 32, from Glasgow, had struggled with her weight since her late teens - but everything changed after using a jab
A mum-of-two, who often cancelled social outings due to feeling "the overweight one," has managed to lose two stone in a mere two months after being treated with Mounjaro. Sarah Hill, 32, an assistant manager at a soft play centre in Glasgow, has grappled with her weight since her late teens.
She would spend hours getting ready for nights out, only to cancel at the last minute due to feelings of discomfort and self-consciousness – she spent years 'staying in the shadows'. Earlier this year, Sarah reached her heaviest weight of 245lbs (17st and 7lbs), and standing at 5ft 4in tall, she frequently felt like a "failure" when stepping on the scales, reports Glasgow Live.
‌
Her wake-up call came with the passing of her grandmother in July 2024, prompting her to take serious steps towards improving her health. Having tried every diet plan under the sun, she decided to give weight loss injections a shot. After years of battling her weight and missing out on cherished moments, Sarah revealed that a weekly dose of Mounjaro has been life-changing – she now feels like "a completely new person."
‌
In a conversation with PA Real Life, she confessed: "I'd get my hair and makeup done to try and make my face look nice, but I couldn't bear the thought of my body in photos. I'd always be in black tights and floaty dresses, trying to cover up. Now I'm planning nights out again and actually showing up. I've got an outfit ready for this weekend and, for once, I'm excited."
Sarah confessed to struggling with her weight since her teenage years, with her heaviest being 245lbs (17st 7lbs) and a dress size 22. "I was bullied in school and it just stuck with me," she explained. "Even in PE, I'd hide in the toilets to get changed."
After having her first child at 17, Sarah's priorities shifted, and she tried various diets, including Cambridge, Slimming World, and calorie counting. Although she lost five stone at one point, she couldn't maintain the weight loss. "I'd pile it back on and end up in an even worse place" she recalled.
Sarah's weight struggles not only affected her physical health but also took a toll on her mental well-being. "I became obsessed with the scales," she revealed. "If I gained a pound, I'd feel like a failure. There were times I cried after weigh-ins."
The catalyst for change came after her grandmother, Sandra, passed away at 70 in July 2024. "She had cancer, and I was one of her main carers at the end," Sarah said. "Losing her broke me. I was grieving, burned out, exhausted from work, and barely moving. That's when I knew something had to change – not just for me, but for my kids."
‌
Sarah initially stumbled upon online discussions about weight loss injections but was dubious about their effectiveness. It wasn't until she saw friends and family achieve real results with the Slim Results programme, a weight management service, that she decided to give it a try.
Mounjaro is an injectable pen utilised for weight loss and the treatment of type 2 diabetes. As per NHS guidelines, Tirzepatide, also known as Mounjaro, is a self-administered weekly injection that aids in prolonging feelings of fullness and curbing hunger. It's recommended that individuals using this injection maintain a balanced diet with fewer calories and partake in regular physical activity.
‌
Mounjaro can be prescribed to people with a BMI exceeding 30 (indicating obesity) and those with a BMI above 27 (signifying overweight) who also suffer from weight-related health complications such as prediabetes, high blood pressure, high cholesterol, or heart conditions. The jab will only be prescribed by a specialist weight management service, where a healthcare professional deems it appropriate treatment.
Obtaining Mounjaro through the NHS for weight management involves a referral to a specialist service, fulfilling certain eligibility requirements, and recognising that access is being implemented gradually. For further details, visit the NHS website.
‌
"I was nervous at first – it's a medication, and there's still so much stigma, but I can honestly say it's the best decision I've ever made," she expressed. Two months on, Sarah has managed to bring her weight down from 245lbs (17st 7lbs) to 216lbs (15st 6lbs). She now comfortably wears a size 14 to 16 and shared that a recent shopping trip felt like a significant accomplishment.
Sarah recalled how she used to steer clear of some fashion stores, like Primark, due to the limited size options, saying: "I used to just avoid Primark like the plague because I felt like I couldn't wear anything," However, her recent visit was a resounding success, as she proudly shared: "I came out with a massive bag yesterday. I was an XXL before, and I got larges and even some mediums. That was a big hit for me."
This experience has left a lasting impression, not just because of the smaller sizes but also because of the sense of inclusivity she now feels. "I felt like I had to go to the plus-size ranges and online to find anything," she explained. Now I can walk in and pick something up. It feels amazing."
‌
Initially, Sarah encountered some side effects from the jab, including fatigue and constipation, but she credits the unwavering support from the Slim Results team for helping her navigate these challenges. "They were brilliant," she praised. "I thought I'd just be sent the jab and that's it, but they were there any time I needed advice – on nutrition, vitamins, everything."
Sarah's dietary habits have also undergone a significant transformation. She revealed: "I used to start the day with two sausage rolls and a large vanilla latte. Now it's overnight oats or fruit and an Americano with a splash of milk. Lunch is soup or salad, and dinner is usually a big plate of veg with some protein – I've always liked food, but now I enjoy meals that actually fuel me."
Sarah has experienced a remarkable boost in self-assurance, leading her to embrace adventures she would have once shied away from. She's excitedly planning a family trip to Disneyland for October, without the usual worries about ride restrictions or feeling self-conscious in the warm weather. "We're going to Disneyland with the kids in October and I'm not panicking about fitting on the rides or covering up in the heat," she expressed.
"I just feel like a new person. I used to be the one behind the camera, never in them. Now I'm proud to be in the picture." While acknowledging there's still a way to go on her journey, Sarah is optimistic about achieving her targets.
When it comes to Mounjaro, the weight loss treatment she's been using, Sarah is eager to share her positive experience. She feels there's a lot of misunderstanding surrounding weight loss injections. "People misunderstand weight loss injections," she said. "They think it's cheating or that you're lazy, but they've never lived in a body that feels like a burden. It's not just a jab. It's a fresh start."

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Daily Mail​

4 hours ago

• Daily Mail​

The Stitch-Up by Emma Szewczak with Dr Andrzej Harris: Help! My vagina has fallen out

The Stitch-Up by Emma Szewczak with Dr Andrzej Harris (Chatto & Windus £22, 288pp) In 2019, Emma Szewczak was being sewn up following the birth of her second child when the midwife paused and said: 'Your vagina's fallen out.' Those words, the author says, were the worst thing anyone had ever said to her. Not even a problematic first experience of childbirth could have prepared her for this. Eventually informed she was suffering a prolapse, she spent three years seeing specialist after specialist, moving from the NHS to private care to the so-called 'wellness' sector, with no one able to offer a solution. Along the course of that journey Szewczak and her husband Dr Andrzej Harris (Associate Professor of Pharmacology at Cambridge) became angrily aware of how many aspects of medicine let women down. Angry and frustrated, they wanted to find out why there's a complete lack of treatment options for conditions (from endometriosis to menopause and everything in between) affecting vast numbers of women across the world. The couple set out to examine 'how medical misogyny harms us all'. The shocking healthcare failures, in medical care and research, may or may not always be the result of institutional 'misogyny' – although most feminists (as I count myself) would level that charge. The problems are acute. In recent years there have been many books on this subject, from Elinor Cleghorn's Unwell Women to Breaking The Taboo by Theo Clarke. The personal stories are bleak, the cold carelessness in female as well as male medical staff often appalling – as Szewczak and Harris make clear. The case for the prosecution mounts: the outrage of vaginal mesh implants, the lack of awareness of potential birth trauma and perinatal psychosis, unnecessary breast surgeries as well as vaginal nips and tucks post-birth, inappropriate intimate examinations, and (of course) the series of maternity hospital scandals, including Shrewsbury and Telford. Endometriosis makes thousands of women suffer but doctors often fail to consider the condition when women seek help for their specific range of symptoms. Why? Underpinning this densely researched book is a simmering rage that women are so often addressed with patronage or indifference. In case you thought the process of birth a doddle, Szewczak provides a frightening litany of possible complications: 'Perinatal tearing… injuries to the pelvic floor… lacerations… episiotomies can become complicated with infection, pain and excessive bleeding… the bladder and urethra can be injured… severe bleeding and shock… damage to the symphysis pubis… postpartum haemorrhage…'. And much more. Who'd be a woman? Which is my problem with the book. For none of the above horrors will be suffered by biological males calling themselves female – or 'trans women', as they would have themselves identified. Yet routinely Szewczak uses the terms 'cis woman' or 'cisgender' for those of us born with the apparatus likely to cause us trouble throughout life, from the first period to the menopause and beyond. How can a book that claims to attack the neglect of women's health dare to belittle the experience of real women by calling it 'cisnormative'? And, astonishingly, just after the dire 'obs-and-gynae' catalogue above, Szewczak, with a degree in gender studies, attacks 'misgendering' (meaning consciously or accidentally calling someone the wrong gender) and 'obscene waiting times for gender-affirming care' for trans people. Is 'misgendering' really as bad as a prolapse or stillbirth? For Szewczak, the answer seems to be yes.

Daily Mirror

15 hours ago

• Daily Mirror

Vicky Pattison makes 'worried' admission as she gives update on 'struggles'

Vicky Pattison has opened up about her "struggles" with food and admitted she has concerns over the use of weight loss jabs. The former Geordie Shore star has previously been open about her battle with "disordered eating" Vicky Pattison has candidly shared her "struggles" with food while voicing her concerns about weight loss jabs. The former queen of the jungle, known for her victory in I'm A Me Out of Here!, has previously discussed her battles with "disordered eating". The reality TV star revealed that she used to count how many blueberries were in her porridge, "restrict calories" and "weaponise exercise" during her lightest periods. Conversely, Vicky confessed to times when she "ate what she wanted" but was then "cruel" to herself. ‌ It comes as Vicky, 37, admits she has her reservations about people using weight loss jabs. The Geordie Shore alum says people using the jabs feels like a "step back" for body positivity. ‌ She expressed her "worries" about the contents of these jabs in an interview with The Sun, questioning: "I've seen women online losing weight on the skinny jabs and they're feeling great and have new-found confidence, and that sounds amazing for them, but do we really know what we're putting into our bodies? No. "I don't think we've got enough information about them, have we? That's what I'm always worried about. It feels like a bit of a step back." Vicky says it is an "absolute shame" that after years of "embracing the body positivity movement" people have started saying "I never wanted to be curvy actually, I always wanted to be skinny." Although the star has "no judgement" towards anyone deciding to take weight loss jabs. She added: "As someone who's spent her life struggling with noise around food and what people thought about us, being the big girl and all the rest of it, whatever makes people happy is none of my business." Currently in England and Wales, doctors have the option to prescribe weight loss injections on the NHS. Treatments such as Saxenda, Wegovy, and Mounjaro can be prescribed, with the latter requiring a specialist's involvement. ‌ Vicky, who tied the knot with Ercan Ramadan last year, shared three pictures of herself at different weights on Instagram in August. She used the post to open up about how she felt about her body. In the post, the celebrity penned: "I used to be cruel to the girl in the first photo... I let her eat what she wanted but I constantly berated her. Called her names and made her feel worthless. Just because of a number on a scale." ‌ The conversation continued as she reflected: "I was cruel to the girl in the second photo as well but in an entirely different way. I would count how many blueberries I put on my porridge, restrict my calories and weaponise exercise. That girl was a nervous wreck." Vicky acknowledged that she was "unhappy" when looking at both photos. She confessed that during those times, she combated "anxiety" and "disordered eating." Adding to her confession, she stated: "Both of these extremes didn't bring me happiness- the unhealthy practices I put my body through over the years brought me anxiety, disordered eating and low self worth. "And even though I'd like to think I've changed and I'm in a better place now- these pictures always serve as a stark reminder of what I put myself through. And what I don't want other women to put themselves through."

Scottish Sun

18 hours ago

• Scottish Sun

Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know

Our round-up also reveals what you need to do if your GP denies you a fat jab prescription and advice if you're intending on buying them privately NATIONAL JAB SERVICE Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called 'fat jabs' will be made available to many more Brits on the NHS. Advertisement 5 From Monday, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind Credit: Getty 5 Health chiefs hope the Mounjaro rollout will turn the tide on England's obesity crisis Credit: Getty In what marks the dawn of a new era, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind. More than three million people are thought to be eligible for tirzepatide - the active drug in Mounjaro - the strongest jab on the market. Health chiefs hope it will turn the tide on England's obesity crisis which has seen rates double since the 1990s. Advertisement Injections including Ozempic and Wegovy have previously only been available for type 2 diabetes or through specialist slimming clinics. Family doctors will now be encouraged to prescribe them in a bid to get more people on the meds. Experts hope widespread use will slash work sick days and boost the economy, while reducing rates of cancer, heart disease and dementia. But demand for the drugs is already huge and NHS clinics cannot dish them out fast enough. Here is everything you need to know as the rollout begins: Advertisement What is Mounjaro and what has it been used for so far? 5 Studies found Mounjaro caused 20 per cent weight loss over 18 months Credit: Reuters FOR anyone who has missed the frenzy, Mounjaro, aka tirzepatide, is the newest weight loss injection used on the NHS. It has been around since 2022 and triggers fullness hormones in the gut to prevent hunger and over-eating. This works the same as older jabs Wegovy and Ozempic, all known as GLP-1 agonists, but a recent trial showed it is more effective. A head-to-head study in the New England Journal of Medicine found Mounjaro caused 20 per cent weight loss over 18 months, while semaglutide – the active ingredient in Wegovy and Ozempic – led to 14 per cent. Advertisement All the jabs were originally invented to treat type 2 diabetes but trials found they could also cause major weight loss. Pharma firms have cashed in on the discovery and UK prescriptions have skyrocketed. NHS prescriptions of Mounjaro in England surged from just 3,300 in 2023 to 1.1million last year, and more than a million people are estimated to be buying it online. Weight Loss Jabs - Pros vs Cons Who will be eligible in the new rollout? THE new rollout starting on Monday will allow GPs to prescribe tirzepatide for weight loss, starting with those patients whose weight places them at greatest health risk. Top of the list will be those with a body mass index (BMI) of 40 or higher and four weight-related health conditions. Advertisement A BMI of 40 is roughly equal to weighing 16st (102kg) for an average height 5'3' woman, or 19st 6lbs (123kg) for an average 5'9' man. Weight-related conditions include high cholesterol, high blood pressure, prediabetes, type 2 diabetes, obstructive sleep apnoea and heart disease. Patients will likely be expected to have tried diet and exercise first before being offered a jab. Many are likely to miss out, as some 13.5million adults in England are obese but only 3.4million are estimated to be eligible in the rollout. How will the rollout be run and what is new? 5 Wes Streeting wants a more widespread use of the drugs but patients must also receive check-ups Credit: Getty Advertisement WHAT'S new is that the rollout will be the first run by NHS primary care, led by GP surgeries. In theory this should make life easier for patients – but GPs will not be able to meet the huge demand. NHS bosses have admitted it will take a staggering 12 years to treat everyone who is eligible. Just 220,000 extra people are likely to get Mounjaro by 2028. Private prescriptions, costing about £100-£150 per month, already vastly outnumber that and are rising. Advertisement Health Secretary Wes Streeting wants a faster rollout and more widespread use of the drugs but patients must also receive regular check-ups and lifestyle help. Officials are investigating whether they can dish them out through pharmacies or the NHS app to take a load off GPs. Professor Jason Halford, of the European Association for the Study of Obesity, said: 'These drugs have the potential to help millions. 'If the government and NHS are serious about prevention they need to reconsider their position on the speed of the rollout of these drugs.' Professor John Deanfield, a heart doctor at University College London, added: 'These drugs provide a real opportunity to delay many diseases of ageing all at the same time and potentially transform society. Advertisement 'I hope it won't take 10 years to do something that is so needed.' What if my GP says no? 5 If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services Credit: Getty MANY people are expected to miss out and some surgeries are already pouring cold water on patients' hopes. Fairhill Medical Practice in Kingston upon Thames said: 'Once we are able to prescribe weight loss injections they will be offered to those with the highest medical need only, which may mean that a lot of patients will be disappointed.' Millions who meet the prescription criteria will simply have to be denied the drugs because doctors are so busy. Advertisement On top of everything else England's 6,300 doctors' surgeries have to deal with, they do not have the capacity to offer the necessary long-term supervision for millions more people at once. Experts reckon private prescriptions will rocket even more as frustrated patients give up waiting. If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services. Known as tier 2 and tier 3 weight management services, they may prescribe the jabs after other weight loss attempts. Many people are expected to find it easier to go private, with the injections widely available from high street pharmacies like Boots, Superdrug, and even Asda. Advertisement Olivier Picard, of the National Pharmacy Association, said: 'NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately.' Advice for people buying them privately BUYING the drugs online might seem like the faster fix – but buyer beware. Slimming success stories are everywhere but so, too, are tales of horror. Many patients have been duped by dodgy sellers, suffered severe side effects or even died after taking jabs they bought online. Bargain prices, easy tick-box applications, or prescriptions with no follow-up, should all be red flags to online shoppers. Advertisement Many pharmacies have been rapped for giving them away to people who do not meet the obesity criteria, potentially putting their health at risk. Dose strength is partly based on size and pretending you are fatter than you are could mean you end up with a medication too strong for your body, raising the risk of serious side effects. The most common side effects from the injections include feeling sick, vomiting, diarrhoea or other gut troubles. If not treated properly people can suffer more serious impacts like dehydration, gallstones, pancreatitis or allergic reactions – and more than 100 deaths in the UK have so far been linked to the jabs. The General Pharmaceutical Council issued new rules in February to say that all pharmacies must verify a patient's height and weight, and conduct at least a video call – if not face-to-face appointment – before prescribing weight loss injections. Advertisement Dr Emily Pegg, associate vice president at Lilly, which makes Mounjaro, said: 'This is still a prescription-only medicine, should only be prescribed by a registered healthcare professional and needs to be dispensed by a registered pharmacy. 'It is not something that people should be able to buy by just going out and going on to a social media site and clicking a button and it gets delivered to them. 'That is not appropriate and is probably illegal. 'Patient safety is a high priority.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Future of fat jabs WHILE the Mounjaro rollout is expected to kick off with a whimper and not a bang, it is hoped it will mark the beginning of a new era in weight loss medicine. Advertisement Brits have been getting gradually fatter for decades and no medication or government policy has managed to beat the bulge. The drugs appear super-effective, reasonably priced and relatively safe, and could help millions slim down after failed diets. They are expected to reduce the risks of type 2 diabetes, cancer and dementia. And studies increasingly show they improve health in other ways on top of weight loss, too, reducing the risk of heart attacks and strokes. NHS medical director, Professor Sir Stephen Powis, believes they could one day be as transformative as cholesterol-lowering statins, which have slashed heart attacks since they were rolled out decades ago. Advertisement Prof Powis said: 'I think over time it's highly likely that these drugs will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'This is very exciting – we're in the foothills of learning how to use them.'